OCGN Stock Alert: Why Is Ocugen Up 20% Today?

Biotechnology firm Ocugen (NASDAQ:OCGN) — which specializes in developing gene therapies to address blindness diseases — saw its shares move higher on an encouraging clinical development. An advisory committee responsible for overseeing safety matters approved Ocugen to use a medium dosage of its…#ocugen #dsmb #peterchang #dsmbchair #ocgn #amd #joshenomoto
Source: Reuters: Health - Category: Consumer Health News Source Type: news